Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Enoxaparin 40 mg Versus 60 mg Dosage for Venous Thromboprophylaxis in Patients Undergoing Bariatric Surgery
TCTR20230117004Phase 4Completed
- Sponsor
- N/A
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by N/A. Started May 2020; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20230117004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230117004.